Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Vipadenant

Generic Name: Vipadenant

Drug Type: Small Molecule

Chemical Formula: C_₁₆H_₁₅N_₇O

CAS Number: 442908-10-3

Unique Ingredient Identifier: LDR3USH1NJ

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in parkinson's disease.

Associated Conditions

No associated conditions information available.

Clinical Trials

BIIB014 Effects on the Pharmacokinetics (PK) of Rosiglitazone, Warfarin, and Midazolam

Phase 1

Completed

Posted: 2009/11/20

Sponsor:Biogen

ID:NCT01017666

Using PET Scans to Study Brain Receptor Occupancy of BIIB014 in Healthy Male Volunteers

Phase 1

Completed

Posted: 2007/09/18

Sponsor:Biogen

ID:NCT00531193

Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease

Phase 2

Completed

Posted: 2007/03/02

Sponsor:Biogen

ID:NCT00442780

Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease

Phase 2

Completed

Posted: 2007/02/22

Sponsor:Biogen

ID:NCT00438607

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy